196 research outputs found

    Клинико-экономичСская ΠΎΡ†Π΅Π½ΠΊΠ° цСлСсообразности примСнСния ΠΊΠ²Π°Π΄Ρ€ΠΈΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с хроничСской сСрдСчной Π½Π΅Π΄ΠΎΡΡ‚Π°Ρ‚ΠΎΡ‡Π½ΠΎΡΡ‚ΡŒΡŽ со сниТСнной Ρ„Ρ€Π°ΠΊΡ†ΠΈΠ΅ΠΉ выброса Π² мСдицинских организациях Московской области

    Get PDF
    Objective: assessment of feasibility of using four-component drug therapy for patients with chronic heart failure with reduced ejection fraction (CHFrEF) in medical organizations of the Moscow Region (MR).Material and methods. Clinical and economic analysis of combined standard therapy with angiotensin-converting enzyme inhibitors, beta-blockers, and mineralocorticoid-receptor antagonists in combination with dapagliflozin (a sodium-glucose cotransporter 2) in the treatment of patients with CHFrEF was carried out. The effectiveness criteria were the number of prevented cardiovascular (CV) deaths and the percentage of the contribution to the achievement of the target indicator to reduce mortality from circulatory diseases within the framework of the regional program β€œHealth care development”. In order to determine the economic feasibility of quadritherapy, direct medical costs for the implemented technology were calculated, the cost of one prevented CV death was determined based on the values of the number needed to treat (NNT) indicator. Budget impact analysis was performed which allowed to build two analytical models. Results. It was shown that the use of quadritherapy can significantly contribute to achieving the target indicator by additionally preventing 512 CV deaths by 2024, which will make it possible to fulfill up to 74.74% of the indicator set by the MR state program β€œHealth care of the Moscow Region” (451.4 persons per 100 thousand population). Using quadruple therapy in 1000 target patients during the first year will prevent 11 CV deaths (NNT 90 persons). The cost of one prevented CV death was 3.860 million rubles. The budget impact analysis made it possible to determine that when CHF patients switch from standard treatment regimens to quadritherapy, including in combination with a drug of the angiotensin/neprilysin receptor inhibitor group (valsartan + sacubitril), this will entail an increase in healthcare system budget costs by 18.8%.Conclusion. The results demonstrate that the standard therapy in combination with the innovative drug dapagliflozin leads to a proven reduction in mortality from circulatory diseases. This technology is a cost-effective approach to organizing medical care for adult patients with CHFrEF on the MR territory.ЦСль: ΠΎΡ†Π΅Π½ΠΊΠ° цСлСсообразности примСнСния Ρ‡Π΅Ρ‚Ρ‹Ρ€Π΅Ρ…ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚Π½ΠΎΠΉ лСкарствСнной Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ для лСчСния ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с хроничСской сСрдСчной Π½Π΅Π΄ΠΎΡΡ‚Π°Ρ‚ΠΎΡ‡Π½ΠΎΡΡ‚ΡŒΡŽ со сниТСнной Ρ„Ρ€Π°ΠΊΡ†ΠΈΠ΅ΠΉ выброса (Π₯БНнЀВ) Π² мСдицинских организациях Московской области (МО).ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π» ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. ΠŸΡ€ΠΎΠ²Π΅Π΄Π΅Π½ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-экономичСский Π°Π½Π°Π»ΠΈΠ· ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡ€ΠΎΠ²Π°Π½Π½ΠΎΠΉ стандартной Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ лСкарствСнными ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π°ΠΌΠΈ классов ΠΈΠ½Π³ΠΈΠ±ΠΈΡ‚ΠΎΡ€ΠΎΠ² Π°Π½Π³ΠΈΠΎΡ‚Π΅Π½Π·ΠΈΠ½ΠΏΡ€Π΅Π²Ρ€Π°Ρ‰Π°ΡŽΡ‰Π΅Π³ΠΎ Ρ„Π΅Ρ€ΠΌΠ΅Π½Ρ‚Π°, Π±Π΅Ρ‚Π°-Π°Π΄Ρ€Π΅Π½ΠΎΠ±Π»ΠΎΠΊΠ°Ρ‚ΠΎΡ€ΠΎΠ², антагонистов ΠΌΠΈΠ½Π΅Ρ€Π°Π»ΠΎΠΊΠΎΡ€Ρ‚ΠΈΠΊΠΎΠΈΠ΄Π½Ρ‹Ρ… Ρ€Π΅Ρ†Π΅ΠΏΡ‚ΠΎΡ€ΠΎΠ² Π² комплСксС с ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠΌ Π³Ρ€ΡƒΠΏΠΏΡ‹ ΠΈΠ½Π³ΠΈΠ±ΠΈΡ‚ΠΎΡ€Π° Π½Π°Ρ‚Ρ€ΠΈΠΉ-глюкозного котранспортСра 2-Π³ΠΎ Ρ‚ΠΈΠΏΠ° Π΄Π°ΠΏΠ°Π³Π»ΠΈΡ„Π»ΠΎΠ·ΠΈΠ½ ΠΏΡ€ΠΈ Π»Π΅Ρ‡Π΅Π½ΠΈΠΈ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π₯БНнЀВ. Π’ качСствС ΠΊΡ€ΠΈΡ‚Π΅Ρ€ΠΈΠ΅Π² эффСктивности выступали ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ количСства ΠΏΡ€Π΅Π΄ΠΎΡ‚Π²Ρ€Π°Ρ‰Π΅Π½Π½Ρ‹Ρ… сСрдСчно-сосудистых (Π‘Π‘) смСртСй ΠΈ ΠΏΡ€ΠΎΡ†Π΅Π½Ρ‚ Π²ΠΊΠ»Π°Π΄Π° Π² достиТСниС Ρ†Π΅Π»Π΅Π²ΠΎΠ³ΠΎ показатСля ΠΏΠΎ сниТСнию смСртности ΠΎΡ‚ Π±ΠΎΠ»Π΅Π·Π½Π΅ΠΉ систСмы кровообращСния Π² Ρ€Π°ΠΌΠΊΠ°Ρ… Ρ€Π΅Π³ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠΉ ΠΏΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌΡ‹ Β«Π Π°Π·Π²ΠΈΡ‚ΠΈΠ΅ здравоохранСния» МО. Π’ цСлях опрСдСлСния экономичСской цСлСсообразности примСнСния ΠΊΠ²Π°Π΄Ρ€ΠΈΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ рассчитаны прямыС мСдицинскиС Π·Π°Ρ‚Ρ€Π°Ρ‚Ρ‹ Π½Π° Π²Π½Π΅Π΄Ρ€ΡΠ΅ΠΌΡƒΡŽ Ρ‚Π΅Ρ…Π½ΠΎΠ»ΠΎΠ³ΠΈΡŽ, ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½Π° ΡΡ‚ΠΎΠΈΠΌΠΎΡΡ‚ΡŒ ΠΎΠ΄Π½ΠΎΠΉ ΠΏΡ€Π΅Π΄ΠΎΡ‚Π²Ρ€Π°Ρ‰Π΅Π½Π½ΠΎΠΉ Π‘Π‘-смСрти Π½Π° основании Π·Π½Π°Ρ‡Π΅Π½ΠΈΠΉ показатСля числа Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ…, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΠΎ ΠΏΡ€ΠΎΠ»Π΅Ρ‡ΠΈΡ‚ΡŒ (Π°Π½Π³Π». number needed to treat, NNT). ΠŸΡ€ΠΎΠ²Π΅Π΄Π΅Π½ Π°Π½Π°Π»ΠΈΠ· влияния Π½Π° Π±ΡŽΠ΄ΠΆΠ΅Ρ‚, Π² Ρ€Π°ΠΌΠΊΠ°Ρ… ΠΊΠΎΡ‚ΠΎΡ€ΠΎΠ³ΠΎ построСны Π΄Π²Π΅ аналитичСскиС ΠΌΠΎΠ΄Π΅Π»ΠΈ.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. Показано, Ρ‡Ρ‚ΠΎ ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΊΠ²Π°Π΄Ρ€ΠΈΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ способно внСсти сущСствСнный Π²ΠΊΠ»Π°Π΄ Π² достиТСниС Ρ†Π΅Π»Π΅Π²ΠΎΠ³ΠΎ показатСля ΠΏΡƒΡ‚Π΅ΠΌ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ прСдотвращСния 512 Π‘Π‘-смСртСй ΠΊ 2024 Π³., Ρ‡Ρ‚ΠΎ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ‚ Π²Ρ‹ΠΏΠΎΠ»Π½ΠΈΡ‚ΡŒ Π΄ΠΎ 74,74% ΠΎΡ‚ ΠΈΠ½Π΄ΠΈΠΊΠ°Ρ‚ΠΎΡ€Π°, установлСнного государствСнной ΠΏΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌΠΎΠΉ МО Β«Π—Π΄Ρ€Π°Π²ΠΎΠΎΡ…Ρ€Π°Π½Π΅Π½ΠΈΠ΅ Подмосковья» (451,4 Ρ‡Π΅Π». Π½Π° 100 тыс. насСлСния). ΠŸΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Ρ‡Π΅Ρ‚Ρ‹Ρ€Π΅Ρ…ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚Π½ΠΎΠΉ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ Ρƒ 1 тыс. Ρ†Π΅Π»Π΅Π²Ρ‹Ρ… ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² Π² Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ ΠΏΠ΅Ρ€Π²ΠΎΠ³ΠΎ Π³ΠΎΠ΄Π° ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ‚ ΠΏΡ€Π΅Π΄ΠΎΡ‚Π²Ρ€Π°Ρ‚ΠΈΡ‚ΡŒ 11 Π‘Π‘-смСртСй (NNT 90 Ρ‡Π΅Π».). Π‘Ρ‚ΠΎΠΈΠΌΠΎΡΡ‚ΡŒ ΠΎΠ΄Π½ΠΎΠΉ ΠΏΡ€Π΅Π΄ΠΎΡ‚Π²Ρ€Π°Ρ‰Π΅Π½Π½ΠΎΠΉ Π‘Π‘-смСрти составила 3,860 ΠΌΠ»Π½ Ρ€ΡƒΠ±. Анализ влияния Π½Π° Π±ΡŽΠ΄ΠΆΠ΅Ρ‚ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ» ΠΎΠΏΡ€Π΅Π΄Π΅Π»ΠΈΡ‚ΡŒ, Ρ‡Ρ‚ΠΎ ΠΏΡ€ΠΈ ΠΏΠ΅Ρ€Π΅Ρ…ΠΎΠ΄Π΅ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π₯БН со стандартных схСм лСчСния Π½Π° ΠΊΠ²Π°Π΄Ρ€ΠΈΡ‚Π΅Ρ€Π°ΠΏΠΈΡŽ, Π² Ρ‚.Ρ‡. Π² ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Ρ†ΠΈΠΈ с ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠΌ Π³Ρ€ΡƒΠΏΠΏΡ‹ ΠΈΠ½Π³ΠΈΠ±ΠΈΡ‚ΠΎΡ€ΠΎΠ² Ρ€Π΅Ρ†Π΅ΠΏΡ‚ΠΎΡ€ΠΎΠ² Π°Π½Π³ΠΈΠΎΡ‚Π΅Π½Π·ΠΈΠ½Π°/Π½Π΅ΠΏΡ€ΠΈΠ»ΠΈΠ·ΠΈΠ½Π° (валсартан + сакубитрил), ΠΏΠΎΠ²Π»Π΅Ρ‡Π΅Ρ‚ Π·Π° собой рост Π·Π°Ρ‚Ρ€Π°Ρ‚ Π±ΡŽΠ΄ΠΆΠ΅Ρ‚Π° систСмы здравоохранСния Π½Π° 18,8%. Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. ΠŸΠΎΠ»ΡƒΡ‡Π΅Π½Π½Ρ‹Π΅ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ Π΄Π΅ΠΌΠΎΠ½ΡΡ‚Ρ€ΠΈΡ€ΡƒΡŽΡ‚, Ρ‡Ρ‚ΠΎ ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ стандартной Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ Π² ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Ρ†ΠΈΠΈ с ΠΈΠ½Π½ΠΎΠ²Π°Ρ†ΠΈΠΎΠ½Π½Ρ‹ΠΌ ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠΌ Π΄Π°ΠΏΠ°Π³Π»ΠΈΡ„Π»ΠΎΠ·ΠΈΠ½ Π²Π΅Π΄Π΅Ρ‚ ΠΊ Π΄ΠΎΠΊΠ°Π·Π°Π½Π½ΠΎΠΌΡƒ сниТСнию смСртности насСлСния ΠΎΡ‚ Π±ΠΎΠ»Π΅Π·Π½Π΅ΠΉ систСмы кровообращСния. Данная тСхнология являСтся экономичСски цСлСсообразным ΠΏΠΎΠ΄Ρ…ΠΎΠ΄ΠΎΠΌ ΠΊ ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΈ мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ взрослым ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π°ΠΌ с Π₯БНнЀВ Π½Π° Ρ‚Π΅Ρ€Ρ€ΠΈΡ‚ΠΎΡ€ΠΈΠΈ МО

    Using reference materials of blast furnace slag, steelmaking slag, converter slag and fused fluxes when developing a procedure for analysis of slag-forming mixtures using inductively coupled plasma atomic emission spectrometry

    Get PDF
    Introduction. Slag-forming mixtures play an important role in obtaining metal without non-metallic inclusions. Required properties of slag-forming mixtures (SFMs) directly depend on their chemical composition, that is why control of individual component content in a mixture is an important stage in the technological chain of metallurgical production. At the present time, it is a common practice to use inductively coupled plasma atomic emission spectrometry (ICP-AES for analyzing SFMs, requiring sample preparation by alloying with alkali fluxes, which makes it impossible to determine potassium and sodium oxides in a sample. That is why it is necessary to work out a procedure for simultaneous determination of calcium, silicon, magnesium, aluminium, potassium, and sodium oxides by the method of ICP-AES, which would include quantitative transferring of all components into a solution. For that purpose, it is suggested to use microwave digestion of samples in autoclaves.The purpose was to develop a procedure for simultaneous determination of specified components of SFMs using ICP-AES after transferring the sample into a solution in an autoclave under conditions of microwave heating, and to certify it reference materials of slag and fluxes.Materials and methods. Compositional analysis of slag-forming mixtures was conducted using an atomic emission spectrometer with inductively coupled plasma Β«iCAP 6500 DuoΒ»; sample digestion was conducted with the use of the microwave system Β«ETHOS PLUSΒ». The following brands of SFMs were chosen as research objects: Melubir 9563 and Accutherm ST-SP/235AL4D; AlsifluxGS-C7; SRCP015, SRCP173P. For calibrating the spectrometer and controlling correctness of determining the specified components, the following reference materials were used: reference materials of blast furnace slag, steelmaking slag, converter slag, and fused fluxes, which have close chemical composition.Research results. An ICP-AES analysis procedure has been developed for calibrating the spectrometer and controlling correctness of determining CaO, SiO2 , MgO, Al2 O3 , K2 O, Na2 O in reference materials of blast furnace slag, steelmaking slag, converter slag and fused fluxes, which allows to establish target components of SFMs quickly and reliably

    Fixed and separate combination of solifenacin and tamsulosin in urinary disorders associated with benign prostatic hyperplasia: a choice based on price and value comparison

    Get PDF
    Objective. To determine the consequences of the use of a fi xed combination of solifenacin and tamsulosin in patientsΒ whom recommended the prescription of these drugs. Methods. Analysis of prices of drugs solifenacin + tamsulosin controlledΒ release (Vasomni), solifenacin (Vesicare), tamsulosin controlled release (Omnic Okas) and tamsulosin modifi ed-release (severalΒ registered trade names of the drug) conducted on the basis of information from several sources: 1 β€” the register of maximumΒ ex-works prices of manufacturers of vital and essential medicines, 2 β€” data on average prices in pharmacies of Moscow (as ofΒ 15.02.2018), 3 β€” weighted average prices of public procurement for 2018 according to the monitoring of the pharmaceuticalΒ market. To determine the points of relative value of drugs, a survey of experts was conducted: 1 β€” to determine the values of theΒ criteria for the drugs under consideration β€” urologists; 2 β€” to determine the weight of the criteria β€” persons involved in theΒ decision-making on the selection and purchase of drugs. Results. We found that the cost of the equivalent course dose of VesomniΒ was on 40-42 % lower than the combination of drugs Vesicar and Omnik Okas. Compared with the non-fi xed combination ofΒ solifenacin with tamsulosin in a drug form with modifi ed release, no signifi cant diff erences in price levels were found. At the sameΒ time, the relative value of a fi xed combination is 5-6 percentage points higher compared to non-fi xed combinations, mainly due to ease of use. Conclusion. Use of a fi xed combination of solifenacin + tamsulosin can lead to budget savings with an increase in the level of relative value

    Influence of the material of weighing bottles on loss-on-drying reproducibility

    Get PDF
    One of the factors influencing the uncertainty of residual moisture measurements in biological medicinal products is the accumulation of electrostatic charge on the surfaces of weighing bottles and laboratory balances, which results in poor weighing reproducibility. The authors believe that the simplest and most economical solution to this problem is to use weighing bottles made of a conductive material, e.g. metal. The aim of the work was to evaluate the influence of the material of weighing bottles on the reproducibility of loss-on-drying (LOD) methods. Materials and methods: Model samples for the study were prepared from a sucrose-gelatin medium by lyophilisation and subsequent moisture sorption to achieve a certain residual moisture content. The authors assessed the samples’ mass uniformity using Shewhart’s X-charts, and analysed their residual moisture content using a loss-on-drying procedure with glass and metal weighing bottles. Statistical processing of the results was carried out by calculating the main statistical indicators: Student’s t-test and Fisher’s F-test. Results: Four batches of model samples were prepared and standardised in terms of average mass using Shewhart’s charts. The effect of weighing bottle materials was most pronounced at low residual moisture contents (less than 0.5%), with the relative standard deviation (RSD) values for the results obtained with glass and metal weighing bottles reaching 76% and 35%, respectively. For the samples with a higher residual moisture content (2–5%), the minimum RSDs with glass and metal weighing bottles were 15% and 6%, respectively. Conclusions: The study allowed for evaluating the influence of the material of weighing bottles on the results of LOD measurements and demonstrated a higher reproducibility with metal weighing bottles. This confirms the possibility of using metal weighing bottles in quality assessment of biological medicinal products for human use with LOD methods

    Lyophilisation of bacterial test strains in a manifold-type apparatus: Effects of freezing and drying parameters, ampoule fill volume, and cotton filter density

    Get PDF
    Scientific relevance. Lyophilisation is the preferred method at the National Collection of Pathogenic MicroorganismsΒ (NCPM) of the Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation. Lyophilisation is used to provide for high standards of test-strain deposition, storage, and transportation and to ensure that test strains maintain their properties. Successful lyophilisation requires conducting experiments to establish the key parameters and critical conditions of the process.Aim. The study aimed to evaluate the effects that the speed and time of freezing, the time of drying, the fill volume of ampoules, and the density of cotton filters have on the quality ofΒ NCPM indicator microorganisms lyophilised in a manifold-type apparatus.Materials and methods. Pseudomonas aeruginosa NCTCΒ 12924, Staphylococcus aureus NCTCΒ 10788, and Salmonella Abony NCTCΒ 6017 were freeze-dried using a manifold-type apparatus (M. S. R. 18, Usifroid). The authors used a low-temperature freezer at –70Β±2Β Β°C for slow freezing and a mixture of dry ice and alcohol for quick freezing. The statistical analysis was performed using Microsoft Excel and StatisticaΒ 10.Results. The minimum time needed for freezing the samples in a low-temperature freezer at –70Β±2Β Β°C was 4 hours. Further storage at this temperature for up to 1Β month was shown possible without compromising the quality of the final product. The time needed for freezing the samples in a mixture of dry ice and alcohol was under 1Β minute. No differences in quality parameters were observed between the lyophilised samples frozen slowly or quickly, except for the cake appearance. Quick freezing resulted in cakes that were non-uniform, crumbled, and pulled away from the ampoule walls, which is considered undesirable. The primary drying stage for ampoules with a fill volume of 0.2 mL took 6–8 hours. The secondary drying stage of 11, 18, 35, and 59 hours resulted in comparable lyophilisate quality: the authors observed no statistically significant differences in viable cell counts (CFU/mL) at the end of lyophilisation and at the end of stress testing. The residual moisture content after 59-hour secondary drying was less than 2%. The cotton filter density had a critical influence on the lyophilisate quality. Therefore, the authors recommend using cotton filters weighing 50Β mg or less.Conclusions. The authors analysed the main stages of the lyophilisation process used for NCPM test strains and considered the effects that the speed and time of freezing, the time of drying, the fill volume of ampoules, and the density of cotton filters have on the quality of the final lyophilised product. The NCPM has implemented the results of this study in its work

    Grain quality indicators and size-dependent fractional composition in winter rye cultivars under the conditions of the Lower Volga region

    Get PDF
    Background. Grain quality indicators of winter rye cultivars were analyzed in connection with the size-dependent fractional composition of their grain in the Lower Volga environments.Materials and methods. The research material included 22 cultivars developed at various Russian scientific institutions, 3 Belarusian ones, and 3 cultivars bred at the Federal Center of Agriculture Research of the South-East Region. Comparative trials were conducted in 2021–2022 on 13.2 m2 plots in two field replications. The following grain quality indicators were studied: grain test weight, 1000 grain weight, size-dependent fractional composition, Hagberg falling number, amylogram peak height, starch gelatinization temperature, protein content, and rheological properties of the meal/water slurry.Results. Protein content was recorded at a level of 9.98–10.85%, while the starch gelatinization temperature was high due to the June air temperatures higher than the norm. Significant differences among the cultivars were found in the fractional composition of grain: 12 forms were identified with medium viscosity of the meal/water slurry and the fine-grain fraction content up to 30% of the total weight.Conclusions. There is a positive significant correlation between the five studied indicators characterizing the rheological properties of the meal/water slurry made from the grain of winter rye cultivars and the grain fraction composition (0.82*–0.91*)

    ΠŸΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ стандартных ΠΎΠ±Ρ€Π°Π·Ρ†ΠΎΠ² Π΄ΠΎΠΌΠ΅Π½Π½Ρ‹Ρ…, ΡΡ‚Π°Π»Π΅ΠΏΠ»Π°Π²ΠΈΠ»ΡŒΠ½Ρ‹Ρ…, ΠΊΠΎΠ½Π²Π΅Ρ€Ρ‚Π΅Ρ€Π½Ρ‹Ρ… шлаков ΠΈ сварочных ΠΏΠ»Π°Π²Π»Π΅Π½Ρ‹Ρ… Ρ„Π»ΡŽΡΠΎΠ² ΠΏΡ€ΠΈ Ρ€Π°Π·Ρ€Π°Π±ΠΎΡ‚ΠΊΠ΅ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊΠΈ Π°Π½Π°Π»ΠΈΠ·Π° ΡˆΠ»Π°ΠΊΠΎΠΎΠ±Ρ€Π°Π·ΡƒΡŽΡ‰ΠΈΡ… смСсСй ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ Π°Ρ‚ΠΎΠΌΠ½ΠΎ-эмиссионной спСктромСтрии с ΠΈΠ½Π΄ΡƒΠΊΡ‚ΠΈΠ²Π½ΠΎ связанной ΠΏΠ»Π°Π·ΠΌΠΎΠΉ

    Get PDF
    Introduction. Slag-forming mixtures play an important role in obtaining metal without non-metallic inclusions. Required properties of slag-forming mixtures (SFMs) directly depend on their chemical composition, that is why control of individual component content in a mixture is an important stage in the technological chain of metallurgical production. At the present time, it is a common practice to use inductively coupled plasma atomic emission spectrometry (ICP-AES for analyzing SFMs, requiring sample preparation by alloying with alkali fluxes, which makes it impossible to determine potassium and sodium oxides in a sample. That is why it is necessary to work out a procedure for simultaneous determination of calcium, silicon, magnesium, aluminium, potassium, and sodium oxides by the method of ICP-AES, which would include quantitative transferring of all components into a solution. For that purpose, it is suggested to use microwave digestion of samples in autoclaves.The purpose was to develop a procedure for simultaneous determination of specified components of SFMs using ICP-AES after transferring the sample into a solution in an autoclave under conditions of microwave heating, and to certify it reference materials of slag and fluxes.Materials and methods. Compositional analysis of slag-forming mixtures was conducted using an atomic emission spectrometer with inductively coupled plasma Β«iCAP 6500 DuoΒ»; sample digestion was conducted with the use of the microwave system Β«ETHOS PLUSΒ». The following brands of SFMs were chosen as research objects: Melubir 9563 and Accutherm ST-SP/235AL4D; AlsifluxGS-C7; SRCP015, SRCP173P. For calibrating the spectrometer and controlling correctness of determining the specified components, the following reference materials were used: reference materials of blast furnace slag, steelmaking slag, converter slag, and fused fluxes, which have close chemical composition.Research results. An ICP-AES analysis procedure has been developed for calibrating the spectrometer and controlling correctness of determining CaO, SiO2 , MgO, Al2 O3 , K2 O, Na2 O in reference materials of blast furnace slag, steelmaking slag, converter slag and fused fluxes, which allows to establish target components of SFMs quickly and reliably.Β Π’Π²Π΅Π΄Π΅Π½ΠΈΠ΅. Π¨Π»Π°ΠΊΠΎΠΎΠ±Ρ€Π°Π·ΡƒΡŽΡ‰ΠΈΠ΅ смСси ΠΈΠ³Ρ€Π°ΡŽΡ‚ Π²Π°ΠΆΠ½ΡƒΡŽ Ρ€ΠΎΠ»ΡŒ для получСния «чистого» ΠΎΡ‚ нСмСталличСских Π²ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠΉ ΠΌΠ΅Ρ‚Π°Π»Π»Π°. НСобходимыС свойства ΡˆΠ»Π°ΠΊΠΎΠΎΠ±Ρ€Π°Π·ΡƒΡŽΡ‰ΠΈΡ… смСсСй (ШОБ) Π½Π°ΠΏΡ€ΡΠΌΡƒΡŽ зависят ΠΎΡ‚ химичСского состава, поэтому ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒ содСрТания ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡƒΠ°Π»ΡŒΠ½Ρ‹Ρ… ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚ΠΎΠ² смСсСй являСтся Π²Π°ΠΆΠ½Ρ‹ΠΌ этапом Π² тСхнологичСской Ρ†Π΅ΠΏΠΈ мСталлургичСского производства. Π’ настоящСС врСмя для Π°Π½Π°Π»ΠΈΠ·Π° ΡˆΠ»Π°ΠΊΠΎΠΎΠ±Ρ€Π°Π·ΡƒΡŽΡ‰Π΅ΠΉ смСси практикуСтся ΠΌΠ΅Ρ‚ΠΎΠ΄ Π°Ρ‚ΠΎΠΌΠ½ΠΎ-эмиссионной спСктромСтрии с ΠΈΠ½Π΄ΡƒΠΊΡ‚ΠΈΠ²Π½ΠΎ связанной ΠΏΠ»Π°Π·ΠΌΠΎΠΉ (АЭБ ИБП), Ρ‚Ρ€Π΅Π±ΡƒΡŽΡ‰ΠΈΠΉ ΠΏΡ€ΠΎΠ±ΠΎΠΏΠΎΠ΄Π³ΠΎΡ‚ΠΎΠ²ΠΊΠΈ ΠΏΡƒΡ‚Π΅ΠΌ сплавлСния с Ρ‰Π΅Π»ΠΎΡ‡Π½Ρ‹ΠΌΠΈ плавнями, Ρ‡Ρ‚ΠΎ Π΄Π΅Π»Π°Π΅Ρ‚ Π½Π΅Π²ΠΎΠ·ΠΌΠΎΠΆΠ½Ρ‹ΠΌ ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ оксидов калия ΠΈ натрия Π² ΠΏΡ€ΠΎΠ±Π΅. ΠŸΠΎΡΡ‚ΠΎΠΌΡƒ сущСствуСт Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΠΎΡΡ‚ΡŒ Ρ€Π°Π·Ρ€Π°Π±ΠΎΡ‚ΠΊΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊΠΈ ΠΎΠ΄Π½ΠΎΠ²Ρ€Π΅ΠΌΠ΅Π½Π½ΠΎΠ³ΠΎ опрСдСлСния оксидов ΠΊΠ°Π»ΡŒΡ†ΠΈΡ, крСмния, магния, алюминия, калия ΠΈ натрия ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ АЭБ ИБП, Π²ΠΊΠ»ΡŽΡ‡Π°ΡŽΡ‰Π΅ΠΉ количСствСнноС ΠΏΠ΅Ρ€Π΅Π²Π΅Π΄Π΅Π½ΠΈΠ΅ всСх ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚ΠΎΠ² Π² раствор. Для этих Ρ†Π΅Π»Π΅ΠΉ ΠΏΡ€Π΅Π΄Π»ΠΎΠΆΠ΅Π½ΠΎ ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΠΎΠ²Π°Ρ‚ΡŒ ΠΌΠΈΠΊΡ€ΠΎΠ²ΠΎΠ»Π½ΠΎΠ²ΠΎΠ΅ Ρ€Π°Π·Π»ΠΎΠΆΠ΅Π½ΠΈΠ΅ ΠΏΡ€ΠΎΠ± Π² Π°Π²Ρ‚ΠΎΠΊΠ»Π°Π²Π°Ρ….ЦСль Ρ€Π°Π±ΠΎΡ‚Ρ‹. Π Π°Π·Ρ€Π°Π±ΠΎΡ‚ΠΊΠ° ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊΠΈ ΠΎΠ΄Π½ΠΎΠ²Ρ€Π΅ΠΌΠ΅Π½Π½ΠΎΠ³ΠΎ опрСдСлСния Π½ΠΎΡ€ΠΌΠΈΡ€ΡƒΠ΅ΠΌΡ‹Ρ… ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚ΠΎΠ² ШОБ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ АЭБ ИБП послС пСрСвСдСния ΠΏΡ€ΠΎΠ±Ρ‹ Π² раствор Π² Π°Π²Ρ‚ΠΎΠΊΠ»Π°Π²Π΅ Π² условиях ΠΌΠΈΠΊΡ€ΠΎΠ²ΠΎΠ»Π½ΠΎΠ²ΠΎΠ³ΠΎ Π½Π°Π³Ρ€Π΅Π²Π°, Π΅Π΅ аттСстация с ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ стандартных ΠΎΠ±Ρ€Π°Π·Ρ†ΠΎΠ² шлаков ΠΈ Ρ„Π»ΡŽΡΠΎΠ².ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. ΠžΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚Π½ΠΎΠ³ΠΎ состава ШОБ ΠΎΡΡƒΡ‰Π΅ΡΡ‚Π²Π»ΡΠ»ΠΎΡΡŒ с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ Π°Ρ‚ΠΎΠΌΠ½ΠΎ-эмиссионного спСктромСтра с ΠΈΠ½Π΄ΡƒΠΊΡ‚ΠΈΠ²Π½ΠΎ связанной ΠΏΠ»Π°Π·ΠΌΠΎΠΉ Β«iCAP 6500 DuoΒ»; Ρ€Π°Π·Π»ΠΎΠΆΠ΅Π½ΠΈΠ΅ ΠΏΡ€ΠΎΠ± ΠΎΡΡƒΡ‰Π΅ΡΡ‚Π²Π»ΡΠ»ΠΎΡΡŒ с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ ΠΌΠΈΠΊΡ€ΠΎΠ²ΠΎΠ»Π½ΠΎΠ²ΠΎΠΉ систСмы Β«ETHOS PLUSΒ». Π’ качСствС ΠΎΠ±ΡŠΠ΅ΠΊΡ‚ΠΎΠ² исслСдования Π²Ρ‹Π±Ρ€Π°Π½Ρ‹ ΡˆΠ»Π°ΠΊΠΎΠΎΠ±Ρ€Π°Π·ΡƒΡŽΡ‰ΠΈΠ΅ смСси ΠΌΠ°Ρ€ΠΎΠΊ Melubir 9563 ΠΈ Accutherm ST-SP/235AL4D; AlsifluxGS-C7; SRCP015, SRCP173P. Для Π³Ρ€Π°Π΄ΡƒΠΈΡ€ΠΎΠ²ΠΊΠΈ спСктромСтра ΠΈ контроля ΠΏΡ€Π°Π²ΠΈΠ»ΡŒΠ½ΠΎΡΡ‚ΠΈ опрСдСлСния Π½ΠΎΡ€ΠΌΠΈΡ€ΡƒΠ΅ΠΌΡ‹Ρ… ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚ΠΎΠ² ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΠΎΠ²Π°Π½Ρ‹ БО шлаков Π΄ΠΎΠΌΠ΅Π½Π½Ρ‹Ρ…, ΡΡ‚Π°Π»Π΅ΠΏΠ»Π°Π²ΠΈΠ»ΡŒΠ½Ρ‹Ρ…, ΠΊΠΎΠ½Π²Π΅Ρ€Ρ‚Π΅Ρ€Π½Ρ‹Ρ…, Π° Ρ‚Π°ΠΊΠΆΠ΅ Ρ„Π»ΡŽΡΠΎΠ² сварочных ΠΏΠ»Π°Π²Π»Π΅Π½Ρ‹Ρ…, ΠΈΠΌΠ΅ΡŽΡ‰ΠΈΡ… Π±Π»ΠΈΠ·ΠΊΠΈΠΉ химичСский состав.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ исслСдования. Π Π°Π·Ρ€Π°Π±ΠΎΡ‚Π°Π½Π° ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊΠ° АЭБ ИБП Π°Π½Π°Π»ΠΈΠ·Π°, прСдназначСнная для Π³Ρ€Π°Π΄ΡƒΠΈΡ€ΠΎΠ²ΠΊΠΈ спСктромСтра ΠΈ контроля ΠΏΡ€Π°Π²ΠΈΠ»ΡŒΠ½ΠΎΡΡ‚ΠΈ опрСдСлСния CaO, SiO2 , MgO, Al2 O3 , K2 O, Na2 O стандартных ΠΎΠ±Ρ€Π°Π·Ρ†ΠΎΠ² шлаков Π΄ΠΎΠΌΠ΅Π½Π½Ρ‹Ρ…, ΡΡ‚Π°Π»Π΅ΠΏΠ»Π°Π²ΠΈΠ»ΡŒΠ½Ρ‹Ρ…, ΠΊΠΎΠ½Π²Π΅Ρ€Ρ‚Π΅Ρ€Π½Ρ‹Ρ… ΠΈ Ρ„Π»ΡŽΡΠΎΠ² сварочных ΠΏΠ»Π°Π²Π»Π΅Π½Ρ‹Ρ…, которая позволяСт быстро ΠΈ Π½Π°Π΄Π΅ΠΆΠ½ΠΎ ΠΎΠΏΡ€Π΅Π΄Π΅Π»ΠΈΡ‚ΡŒ Ρ†Π΅Π»Π΅Π²Ρ‹Π΅ ΠΊΠΎΠΌΠΏΠΎΠ½Π΅Π½Ρ‚Ρ‹ ШОБ

    ВлияниС ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Π° бюксов Π½Π° Π²ΠΎΡΠΏΡ€ΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΠΌΠΎΡΡ‚ΡŒ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊΠΈ опрСдСлСния ΠΏΠΎΡ‚Π΅Ρ€ΠΈ Π² массС ΠΏΡ€ΠΈ Π²Ρ‹ΡΡƒΡˆΠΈΠ²Π°Π½ΠΈΠΈ

    Get PDF
    One of the factors influencing the uncertainty of residual moisture measurements in biological medicinal products is the accumulation of electrostatic charge on the surfaces of weighing bottles and laboratory balances, which results in poor weighing reproducibility. The authors believe that the simplest and most economical solution to this problem is to use weighing bottles made of a conductive material, e.g. metal. The aim of the work was to evaluate the influence of the material of weighing bottles on the reproducibility of loss-on-drying (LOD) methods. Materials and methods: Model samples for the study were prepared from a sucrose-gelatin medium by lyophilisation and subsequent moisture sorption to achieve a certain residual moisture content. The authors assessed the samples’ mass uniformity using Shewhart’s X-charts, and analysed their residual moisture content using a loss-on-drying procedure with glass and metal weighing bottles. Statistical processing of the results was carried out by calculating the main statistical indicators: Student’s t-test and Fisher’s F-test. Results: Four batches of model samples were prepared and standardised in terms of average mass using Shewhart’s charts. The effect of weighing bottle materials was most pronounced at low residual moisture contents (less than 0.5%), with the relative standard deviation (RSD) values for the results obtained with glass and metal weighing bottles reaching 76% and 35%, respectively. For the samples with a higher residual moisture content (2–5%), the minimum RSDs with glass and metal weighing bottles were 15% and 6%, respectively. Conclusions: The study allowed for evaluating the influence of the material of weighing bottles on the results of LOD measurements and demonstrated a higher reproducibility with metal weighing bottles. This confirms the possibility of using metal weighing bottles in quality assessment of biological medicinal products for human use with LOD methods.Одним ΠΈΠ· Ρ„Π°ΠΊΡ‚ΠΎΡ€ΠΎΠ², Π²Π»ΠΈΡΡŽΡ‰ΠΈΡ… Π½Π° Π½Π΅ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½Π½ΠΎΡΡ‚ΡŒ ΠΈΠ·ΠΌΠ΅Ρ€Π΅Π½ΠΈΠΉ остаточной влаТности биологичСских лСкарствСнных ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ², являСтся Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ΠΈΠ΅ элСктростатичСского заряда Π½Π° повСрхностях Π²Π·Π²Π΅ΡˆΠΈΠ²Π°Π΅ΠΌΡ‹Ρ… бюксов ΠΈ вСсов, Ρ‡Ρ‚ΠΎ выраТаСтся Π² Π½ΠΈΠ·ΠΊΠΎΠΉ воспроизводимости Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΎΠ² взвСшивания. НаиболСС простым ΠΈ экономичным способом Ρ€Π΅ΡˆΠ΅Π½ΠΈΡ Π΄Π°Π½Π½ΠΎΠΉ ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌΡ‹, ΠΏΠΎ Π½Π°ΡˆΠ΅ΠΌΡƒ мнСнию, являСтся использованиС бюксов ΠΈΠ· элСктропроводящих ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»ΠΎΠ², Π½Π°ΠΏΡ€ΠΈΠΌΠ΅Ρ€ мСталличСских. ЦСль Ρ€Π°Π±ΠΎΡ‚Ρ‹: ΠΎΡ†Π΅Π½ΠΈΡ‚ΡŒ влияниС ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Π° бюксов Π½Π° Π²ΠΎΡΠΏΡ€ΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΠΌΠΎΡΡ‚ΡŒ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊΠΈ опрСдСлСния ΠΏΠΎΡ‚Π΅Ρ€ΠΈ Π² массС ΠΏΡ€ΠΈ Π²Ρ‹ΡΡƒΡˆΠΈΠ²Π°Π½ΠΈΠΈ. ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹: ΠΌΠΎΠ΄Π΅Π»ΡŒΠ½Ρ‹Π΅ ΠΎΠ±Ρ€Π°Π·Ρ†Ρ‹ для провСдСния исслСдований Π³ΠΎΡ‚ΠΎΠ²ΠΈΠ»ΠΈ Π½Π° основС сахарозо-ΠΆΠ΅Π»Π°Ρ‚ΠΈΠ½ΠΎΠ²ΠΎΠΉ срСды способом Π»ΠΈΠΎΡ„ΠΈΠ»ΠΈΠ·Π°Ρ†ΠΈΠΈ ΠΈ ΠΏΠΎΡΠ»Π΅Π΄ΡƒΡŽΡ‰Π΅ΠΉ сорбциСй Π²Π»Π°Π³ΠΈ Π΄ΠΎ ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½Π½Ρ‹Ρ… Π·Π½Π°Ρ‡Π΅Π½ΠΈΠΉ остаточной влаТности. ΠžΡ†Π΅Π½ΠΊΡƒ однородности ΠΌΠΎΠ΄Π΅Π»ΡŒΠ½Ρ‹Ρ… ΠΎΠ±Ρ€Π°Π·Ρ†ΠΎΠ² ΠΏΠΎ массС ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ с ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ Π₯-ΠΊΠ°Ρ€Ρ‚ Π¨ΡƒΡ…Π°Ρ€Ρ‚Π°. ΠžΠΏΡ€Π΅Π΄Π΅Π»ΡΠ»ΠΈ ΠΏΠΎΡ‚Π΅Ρ€ΡŽ Π² массС ΠΏΡ€ΠΈ Π²Ρ‹ΡΡƒΡˆΠΈΠ²Π°Π½ΠΈΠΈ ΠΌΠΎΠ΄Π΅Π»ΡŒΠ½Ρ‹Ρ… ΠΎΠ±Ρ€Π°Π·Ρ†ΠΎΠ² с использованиСм стСклянных ΠΈ мСталличСских бюксов. Π‘Ρ‚Π°Ρ‚ΠΈΡΡ‚ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ ΠΎΠ±Ρ€Π°Π±ΠΎΡ‚ΠΊΡƒ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΎΠ² ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ, рассчитывая основныС статистичСскиС ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ, t-ΠΊΡ€ΠΈΡ‚Π΅Ρ€ΠΈΠΉ Π‘Ρ‚ΡŒΡŽΠ΄Π΅Π½Ρ‚Π°, ΠΊΡ€ΠΈΡ‚Π΅Ρ€ΠΈΠΉ Π€ΠΈΡˆΠ΅Ρ€Π°. Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹: ΠΏΠΎΠ΄Π³ΠΎΡ‚ΠΎΠ²Π»Π΅Π½Ρ‹ ΠΈ стандартизированы Ρ‡Π΅Ρ‚Ρ‹Ρ€Π΅ сСрии ΠΌΠΎΠ΄Π΅Π»ΡŒΠ½Ρ‹Ρ… ΠΎΠ±Ρ€Π°Π·Ρ†ΠΎΠ² с ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΠΊΠ°Ρ€Ρ‚ Π¨ΡƒΡ…Π°Ρ€Ρ‚Π° ΠΏΠΎ срСднСй массС. ВлияниС ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Π° бюксов Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ сильно проявляСтся ΠΏΡ€ΠΈ Π½ΠΈΠ·ΠΊΠΎΠΉ остаточной влаТности ΠΌΠΎΠ΄Π΅Π»ΡŒΠ½Ρ‹Ρ… ΠΎΠ±Ρ€Π°Π·Ρ†ΠΎΠ² (ΠΌΠ΅Π½Π΅Π΅ 0,5%): ΠΎΡ‚Π½ΠΎΡΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ΅ стандартноС ΠΎΡ‚ΠΊΠ»ΠΎΠ½Π΅Π½ΠΈΠ΅ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΎΠ² ΠΈΠ·ΠΌΠ΅Ρ€Π΅Π½ΠΈΠΉ ΠΏΠΎΡ‚Π΅Ρ€ΠΈ Π² массС ΠΏΡ€ΠΈ Π²Ρ‹ΡΡƒΡˆΠΈΠ²Π°Π½ΠΈΠΈ ΠΏΠΎΠ»ΡƒΡ‡Π°Π΅ΠΌΡ‹Ρ… ΠΏΡ€ΠΈ использовании стСклянных бюксов достигало 76%, ΠΏΡ€ΠΈ использовании мСталличСских бюксов β€” 35%. ΠŸΡ€ΠΈ большСй остаточной влаТности ΠΎΠ±Ρ€Π°Π·Ρ†ΠΎΠ² (2–5%) минимальноС ΠΎΡ‚Π½ΠΎΡΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ΅ стандартноС ΠΎΡ‚ΠΊΠ»ΠΎΠ½Π΅Π½ΠΈΠ΅ составляло 15% ΠΏΡ€ΠΈ использовании стСклянных бюксов ΠΈ 6% ΠΏΡ€ΠΈ использовании мСталличСских бюксов. Π’Ρ‹Π²ΠΎΠ΄Ρ‹: ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½Π½Ρ‹Π΅ исслСдования ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ»ΠΈ ΠΎΡ†Π΅Π½ΠΈΡ‚ΡŒ влияниС ΠΌΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Π° бюксов Π½Π° Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ опрСдСлСния ΠΏΠΎΡ‚Π΅Ρ€ΠΈ Π² массС ΠΏΡ€ΠΈ Π²Ρ‹ΡΡƒΡˆΠΈΠ²Π°Π½ΠΈΠΈ: ΠΏΠΎΠΊΠ°Π·Π°Π½Π° Π±ΠΎΠ»Π΅Π΅ высокая Π²ΠΎΡΠΏΡ€ΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΠΌΠΎΡΡ‚ΡŒ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΎΠ² испытаний с использованиСм мСталличСских бюксов, Ρ‡Ρ‚ΠΎ ΠΏΠΎΠ΄Ρ‚Π²Π΅Ρ€ΠΆΠ΄Π°Π΅Ρ‚ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡ‚ΡŒ ΠΈΡ… использования ΠΏΡ€ΠΈ ΠΎΡ†Π΅Π½ΠΊΠ΅ качСства биологичСских лСкарствСнных ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠ² ΠΏΠΎ ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΡŽ Β«ΠŸΠΎΡ‚Π΅Ρ€Ρ Π² массС ΠΏΡ€ΠΈ Π²Ρ‹ΡΡƒΡˆΠΈΠ²Π°Π½ΠΈΠΈΒ»

    ΠžΡΠ½ΠΎΠ²Π½Ρ‹Π΅ направлСния Π°Π½Π°Π»ΠΈΠ·Π° экономичСских Π·Π°Ρ‚Ρ€Π°Ρ‚ ΠΏΡ€ΠΈ ΠΎΠΊΠ°Π·Π°Π½ΠΈΠΈ онкологичСской ΠΏΠΎΠΌΠΎΡ‰ΠΈ насСлСнию

    Get PDF
    Introduction. The economic aspects of providing cancer care to the public attract increasing attention of scientists, economists, physicians and other healthcare professionals. Currently, the healthcare economics of oncological institutions is defined as part of the national economy that implements cancer care programs and provide a wide range of medical and pharmaceutical services to the public.Aim. The study was conducted as part of the program for improvement of financial spending in order to facilitate cancer care for Moscow residents. The aim of this study was to identify the crucial areas of the cost analysis and thus improve the public health service.Materials and methods. We used the methodology of targeted and consistent search of the literature. The data search and analysis was carried out using the US National Medical Library (PubMed database), National Electronic Library (e-LIBRARY, Russia), and other Internet resources. Whenever possible, articles on the most common and socially significant types of cancer (breast, colon, prostate, lung etc.) were selected. In addition, we focused on significant studies conducted either on the national or international level.Results and discussion. In principle, the structure of total costs is determined by the health policy regarding the cancer care system. Six main areas of oncological care that require careful economic analysis have been identified: those are prevention, oncoscreening, diagnosis, treatment, rehabilitation, and palliative care. In order to implement the economic goals of the healthcare system, the cost of cancer treatment should be discussed. The relevant programs are expected to be based on 1) prevalence and incidence; 2) impact on health; 3) results of the integrative methodological approach to cancer treatment; 4) implementation of comprehensive measures of medical and social assistance; 5) use of financial mechanisms and their impact on economic indicators.Conclusion. The set of measures related to the direct costs as identified in this study include the development, planning and provision of cancer care. These specific features of the direct cost analysis are important for organizing medical care in oncological institutions.Π’Π²Π΅Π΄Π΅Π½ΠΈΠ΅. ЭкономичСскиС вопросы обСспСчСния онкологичСской ΠΏΠΎΠΌΠΎΡ‰ΠΈ насСлСнию ΠΏΡ€ΠΈΠ²Π»Π΅ΠΊΠ°ΡŽΡ‚ всС большСС Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ со стороны ΡƒΡ‡Π΅Π½Ρ‹Ρ…-экономистов, Π²Ρ€Π°Ρ‡Π΅ΠΉ-ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ‚ΠΎΡ€ΠΎΠ² здравоохранСния, мСдицинских ΠΌΠ΅Π½Π΅Π΄ΠΆΠ΅Ρ€ΠΎΠ². Π’ настоящСС врСмя ΠΏΠΎΠ΄ экономикой здравоохранСния ΡƒΡ‡Ρ€Π΅ΠΆΠ΄Π΅Π½ΠΈΠΉ онкологичСского профиля понимаСтся ΠΏΡ€Π΅ΠΆΠ΄Π΅ всСго отраслСвая экономика Π½Π°Ρ€ΠΎΠ΄Π½ΠΎΠ³ΠΎ хозяйства, Ρ€Π΅Π°Π»ΠΈΠ·ΡƒΡŽΡ‰Π°Ρ ΠΏΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌΡ‹ ΠΏΠΎ ΡΠΎΡ…Ρ€Π°Π½Π΅Π½ΠΈΡŽ ΠΈ ΡƒΠΊΡ€Π΅ΠΏΠ»Π΅Π½ΠΈΡŽ ΠΎΠ±Ρ‰Π΅Π³ΠΎ Π·Π΄ΠΎΡ€ΠΎΠ²ΡŒΡ Π³Ρ€Π°ΠΆΠ΄Π°Π½, ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΠΊΠΈ ΠΎΠ½ΠΊΠΎΠ·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ ΠΈ ΠΈΡ… распространСния, прСдоставлСния ΡˆΠΈΡ€ΠΎΠΊΠΎΠ³ΠΎ ряда мСдицинских ΠΈ фармацСвтичСских услуг ΠΏΠΎ Π·Π°Π΄Π°Π½Π½Ρ‹ΠΌ направлСниям мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ.ЦСль – идСнтификация Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π²Π°ΠΆΠ½Ρ‹Ρ… Π½Π°ΠΏΡ€Π°Π²Π»Π΅Π½ΠΈΠΉ для Π°Π½Π°Π»ΠΈΠ·Π° экономичСских Π·Π°Ρ‚Ρ€Π°Ρ‚, Π²Π»ΠΈΡΡŽΡ‰ΠΈΡ… Π½Π° ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ оказания мСдицинских услуг ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π°ΠΌ с онкологичСскими заболСваниями.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. Π’ Ρ€Π°Π±ΠΎΡ‚Π΅ ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½Π° мСтодология Ρ†Π΅Π»Π΅Π²ΠΎΠ³ΠΎ ΠΈ смыслового поиска источников Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Ρ‹. Поиск ΠΈ Π°Π½Π°Π»ΠΈΠ· Π΄Π°Π½Π½Ρ‹Ρ… ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½ с использованиСм ΠΠ°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠΉ мСдицинской Π±ΠΈΠ±Π»ΠΈΠΎΡ‚Π΅ΠΊΠΈ БША (Π±Π°Π·Π° Π΄Π°Π½Π½Ρ‹Ρ… PubMed), ΠΈΠ½Ρ‚Π΅Ρ€Π½Π΅Ρ‚-рСсурсов, ΠΠ°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠΉ элСктронной Π±ΠΈΠ±Π»ΠΈΠΎΡ‚Π΅ΠΊΠΈ (НЭБ) e-LIBRARY (Россия). ΠžΡ‚Π±ΠΈΡ€Π°Π»ΠΈΡΡŒ ΡΡ‚Π°Ρ‚ΡŒΠΈ, посвящСнныС Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ распространСнным ΠΈ ΡΠΎΡ†ΠΈΠ°Π»ΡŒΠ½ΠΎ Π·Π½Π°Ρ‡ΠΈΠΌΡ‹ΠΌ Π²ΠΈΠ΄Π°ΠΌ Ρ€Π°ΠΊΠ° (Ρ€Π°ΠΊ ΠΌΠΎΠ»ΠΎΡ‡Π½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹, ΠΎΠ±ΠΎΠ΄ΠΎΡ‡Π½ΠΎΠΉ кишки, ΠΏΡ€Π΅Π΄ΡΡ‚Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ‹, Ρ€Π°ΠΊ Π»Π΅Π³ΠΊΠΎΠ³ΠΎ ΠΈ Ρ‚. Π΄.). ΠšΡ€ΠΎΠΌΠ΅ Ρ‚ΠΎΠ³ΠΎ, Π²ΠΎ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅, Π³Π»Π°Π²Π½Ρ‹ΠΌ ΠΎΠ±Ρ€Π°Π·ΠΎΠΌ, ΠΏΡ€ΠΈΠ½ΠΈΠΌΠ°Π»ΠΈΡΡŒ ΠΊΡ€ΡƒΠΏΠ½Ρ‹Π΅ исслСдования, ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½Π½Ρ‹Π΅ Π½Π° ΡƒΡ€ΠΎΠ²Π½Π΅ ΠΎΡ‚Π΄Π΅Π»ΡŒΠ½Ρ‹Ρ… государств ΠΈΠ»ΠΈ ΠΎΠ±ΠΎΠ±Ρ‰Π°ΡŽΡ‰ΠΈΠ΅ ΠΎΠΏΡ‹Ρ‚ Π½Π΅ΡΠΊΠΎΠ»ΡŒΠΊΠΈΡ… стран.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ ΠΈ обсуТдСниС. ΠŸΡ€ΠΈΠ½Ρ†ΠΈΠΏΡ‹ формирования ΠΎΠ±Ρ‰ΠΈΡ… Π·Π°Ρ‚Ρ€Π°Ρ‚ ΠΏΡ€ΠΎΠ΄ΠΈΠΊΡ‚ΠΎΠ²Π°Π½Ρ‹ ΠΏΠΎΠ»ΠΈΡ‚ΠΈΠΊΠΎΠΉ здравоохранСния Π² ΠΎΡ‚Π½ΠΎΡˆΠ΅Π½ΠΈΠΈ систСмы оказания онкологичСской ΠΏΠΎΠΌΠΎΡ‰ΠΈ. Π˜Π΄Π΅Π½Ρ‚ΠΈΡ„ΠΈΡ†ΠΈΡ€ΠΎΠ²Π°Π½ΠΎ ΡˆΠ΅ΡΡ‚ΡŒ основных Π½Π°ΠΏΡ€Π°Π²Π»Π΅Π½ΠΈΠΉ онкологичСской ΠΏΠΎΠΌΠΎΡ‰ΠΈ, Π½Π° обСспСчСниС ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… Ρ€Π°ΡΠΏΡ€Π΅Π΄Π΅Π»ΡΡŽΡ‚ΡΡ финансовыС срСдства, ΠΏΠΎΠ΄Π»Π΅ΠΆΠ°Ρ‰ΠΈΠ΅ Ρ‚Ρ‰Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠΌΡƒ экономичСскому Π°Π½Π°Π»ΠΈΠ·Ρƒ: ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΠΊΠ°, онкоскрининг, диагностика, Π»Π΅Ρ‡Π΅Π½ΠΈΠ΅, рСабилитация, паллиативная ΠΏΠΎΠΌΠΎΡ‰ΡŒ. Π’ цСлях Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ экономичСских Π·Π°Π΄Π°Ρ‡ систСмы здравоохранСния слСдуСт ΠΎΠ±ΡΡƒΠΆΠ΄Π°Ρ‚ΡŒ пСрспСктивныС ΠΏΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌΡ‹, посвящСнныС вопросам Π·Π°Ρ‚Ρ€Π°Ρ‚ Π½Π° Π»Π΅Ρ‡Π΅Π½ΠΈΠ΅ Ρ€Π°ΠΊΠ°. Π­Ρ‚ΠΈ ΠΏΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌΡ‹ Ρ„ΠΎΡ€ΠΌΠΈΡ€ΡƒΡŽΡ‚ΡΡ Π½Π° основании Ρ‚Π°ΠΊΠΈΡ… ΠΊΠΎΡ€Ρ€Π΅Π»ΠΈΡ€ΡƒΡŽΡ‰ΠΈΡ… Π΄Π°Π½Π½Ρ‹Ρ…, ΠΊΠ°ΠΊ: 1) Ρ€Π°ΡΠΏΡ€ΠΎΡΡ‚Ρ€Π°Π½Π΅Π½Π½ΠΎΡΡ‚ΡŒ ΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡ‚ΡŒ; 2) ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ воздСйствия Π½Π° Π·Π΄ΠΎΡ€ΠΎΠ²ΡŒΠ΅; 3) Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ внСдрСния ΠΈΠ½Ρ‚Π΅Π³Ρ€Π°Ρ‚ΠΈΠ²Π½ΠΎΠ³ΠΎ мСтодичСского ΠΏΠΎΠ΄Ρ…ΠΎΠ΄Π° ΠΊ Π»Π΅Ρ‡Π΅Π½ΠΈΡŽ Ρ€Π°ΠΊΠ°; 4) исходы примСнСния всСсторонних ΠΌΠ΅Ρ€ ΠΏΠΎ оказанию мСдицинской ΠΈ ΡΠΎΡ†ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ ΠΏΠΎΠΌΠΎΡ‰ΠΈ; 5) Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ внСдрСния финансовых ΠΌΠ΅Ρ…Π°Π½ΠΈΠ·ΠΌΠΎΠ² ΠΈ ΠΈΡ… влияниС Π½Π° экономичСскиС ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ.Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. Π’ ΡΠΎΠ²Ρ€Π΅ΠΌΠ΅Π½Π½ΡƒΡŽ ΠΏΡ€ΠΎΡ„Π΅ΡΡΠΈΠΎΠ½Π°Π»ΡŒΠ½ΡƒΡŽ Π΄Π΅ΡΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ всСх участников мСдицинской отрасли Π²Ρ…ΠΎΠ΄ΠΈΡ‚ Ρ€Π°Π·Ρ€Π°Π±ΠΎΡ‚ΠΊΠ°, ΠΏΠ»Π°Π½ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΈ обСспСчСниС комплСкса ΠΌΠ΅Ρ€, связанных, Π³Π»Π°Π²Π½Ρ‹ΠΌ ΠΎΠ±Ρ€Π°Π·ΠΎΠΌ, с прямыми Π·Π°Ρ‚Ρ€Π°Ρ‚Π°ΠΌΠΈ Π½Π° ΠΈΠ΄Π΅Π½Ρ‚ΠΈΡ„ΠΈΡ†ΠΈΡ€ΠΎΠ²Π°Π½Π½Ρ‹Π΅ Π² нашСй Ρ€Π°Π±ΠΎΡ‚Π΅ направлСния. ВыявлСниС Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π²Π°ΠΆΠ½Ρ‹Ρ… для ΠΏΠΎΡΠ»Π΅Π΄ΡƒΡŽΡ‰Π΅Π³ΠΎ исслСдования особСнностСй прямых Π·Π°Ρ‚Ρ€Π°Ρ‚ Π½Π° ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΡŽ Ρ€Π°Π±ΠΎΡ‚Ρ‹ основных Π½Π°ΠΏΡ€Π°Π²Π»Π΅Π½ΠΈΠΉ мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ Π² совокупности с ассоциированными показатСлями эффСктивности ΠΌΠΎΠΆΠ΅Ρ‚ ΡΠΏΠΎΡΠΎΠ±ΡΡ‚Π²ΠΎΠ²Π°Ρ‚ΡŒ ΡΠΎΠ²Π΅Ρ€ΡˆΠ΅Π½ΡΡ‚Π²ΠΎΠ²Π°Π½ΠΈΡŽ Π΄Π΅ΡΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΠΈ ΡƒΡ‡Ρ€Π΅ΠΆΠ΄Π΅Π½ΠΈΠΉ здравоохранСния онкологичСского профиля
    • …
    corecore